周四下午，法兰克福DAX指数延续上涨势头，突破24400点，创下历史新高，投资者对欧洲央行普遍预期的最新政策举措表示欢迎。央行将存款利率从2.25%下调至2%，这是连续第八次下调，以缓解通货膨胀和与贸易有关的地区增长风险。最值得注意的是，欧洲央行还下调了2025年和2026年的通胀预测。在国内数据方面，德国4月份工厂订单意外上升，打破了下降的预测，反映了强劲的国内和欧元区需求。在股票中，受高盛将其股票评级从中性上调至买入以及美国食品和药物管理局批准扩大其前列腺癌症药物Nubeqa的使用，拜耳以超过5%的涨幅居指数首位。其他表现突出的公司包括海德堡材料公司和莱茵金属公司，分别上涨4.3%和3.6%。
Frankfurt's DAX extended its upward momentum to trade above 24,400 on Thursday afternoon, setting new record levels, as investors welcomed the ECB’s widely expected latest policy move. The central bank cut its deposit rate to 2% from 2.25%, marking the eighth consecutive reduction, amid easing inflation and trade-related risks to regional growth. Most notably, the ECB also revised its inflation forecasts downward for both 2025 and 2026. On the domestic data front, German factory orders unexpectedly rose in April, defying forecasts of a decline, reflecting robust domestic and euro area demand. Among stocks, Bayer topped the index with a jump of over 5%, boosted by Goldman Sachs upgrading its stock rating from Neutral to Buy and the US FDA’s approval of expanded use for its prostate cancer drug Nubeqa. Other notable performers included Heidelberg Materials and Rheinmetall, rising 4.3% and 3.6%, respectively.
